Suppr超能文献

铁蛋白升高可预测皮肌炎并发症急性间质性肺病的发生和严重程度。

Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis.

机构信息

Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan.

出版信息

Rheumatology (Oxford). 2010 Jul;49(7):1354-60. doi: 10.1093/rheumatology/keq073. Epub 2010 Apr 12.

Abstract

OBJECTIVES

Acute/subacute interstitial pneumonia (A/SIP) is an intractable and fatal complication of DM. Since a useful indicator predicting the complication of A/SIP has not been found, the aim of this study was to determine whether serum ferritin is a potential predictive indicator of the occurrence of A/SIP in 64 patients with DM.

METHODS

Of the total patients enrolled, 19 had A/SIP, 24 had chronic interstitial pneumonia and 21 were without interstitial lung disease (ILD). Clinical manifestations and laboratory data were obtained from medical records on admission.

RESULTS

Serum ferritin levels were extremely high in patients with DM with A/SIP. It was significantly higher in DM with A/SIP than that in DM without A/SIP (median 790 vs 186 ng/ml; P < 0.0001). The cumulative survival rate for 6 months was 62.7% in patients with DM with A/SIP. Moreover, the cumulative survival rate was significantly (P = 0.016) lower in the group with ferritin levels > or =1500 ng/ml than the rate in the group with ferritin levels <1500 ng/ml.

CONCLUSIONS

Serum ferritin can be useful as a predictor of the occurrence of A/SIP and correlates with the prognosis of A/SIP in DM. The intensive treatment using combination therapy with various immunosuppressant agents should be chosen for patients with ILD with DM showing hyperferritinaemia, especially levels >1500 ng/ml.

摘要

目的

急性/亚急性间质性肺炎(A/SIP)是糖尿病的一种难治性且致命的并发症。由于尚未发现预测 A/SIP 并发症的有用指标,因此本研究旨在确定血清铁蛋白是否是预测 64 例糖尿病患者发生 A/SIP 的潜在指标。

方法

总共有 19 例患者患有 A/SIP,24 例患有慢性间质性肺炎,21 例患者无间质性肺病(ILD)。从入院病历中获取临床表现和实验室数据。

结果

患有 A/SIP 的糖尿病患者的血清铁蛋白水平极高。患有 A/SIP 的糖尿病患者的血清铁蛋白水平明显高于无 A/SIP 的糖尿病患者(中位数为 790 与 186ng/ml;P<0.0001)。患有 A/SIP 的糖尿病患者的 6 个月累积生存率为 62.7%。此外,铁蛋白水平>或=1500ng/ml 的组的累积生存率明显低于铁蛋白水平<1500ng/ml 的组(P=0.016)。

结论

血清铁蛋白可作为预测 A/SIP 发生的指标,并与糖尿病 A/SIP 的预后相关。对于显示高血清铁蛋白血症的糖尿病合并ILD 患者,特别是铁蛋白水平>1500ng/ml 的患者,应选择联合使用各种免疫抑制剂的强化治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验